Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, Ludovico, Ojha, Ravi, Pedro, Liliana D., Djannatian, Minou, Franz, Jonas, Kuivanen, Suvi, van der Meer, Franziska, Kallio, Katri +21 more·2020·Science
DOI 10.1126/science.abd2985

Cited by (1,003)

Items 801–900 of 1,003

  1. SARS‐CoV‐2, periodontal pathogens, and host factors: The trinity of oral post‐acute sequelae of COVID‐19
    JOEL L. SCHWARTZ, Kristelle J. Capistrano, Joseph Gluck, Armita Hezarkhani, Afsar Raza Naqvi · 2024 · Reviews in Medical Virology
  2. COVID-19: from immune response to clinical intervention
    Zheng-yang Guo, Yanqing Tang, Zi-bo Zhang, Juan Liu, Yuxin Zhuang, Ting Li · 2024 · Precision Clinical Medicine
  3. Полювання вчених на коронавірус SARS-COV-2, що викликає COVID-19: наукові стратегії подолання пандемії
    С. В. Комісаренко · 2020 · Visnik Nacional noi academii nauk Ukrai ni
  4. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections
    Abdulaziz Alamri, Derek Fisk, Deepak Upreti, Sam K. P. Kung · 2021 · International Journal of Molecular Sciences
  5. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations
    Gianluigi Pironti, Daniel C. Andersson, Lars H. Lund · 2021 · Frontiers in Cell and Developmental Biology
  6. Pancreatic β‐cell fate in subjects with COVID‐19
    Jun Shirakawa · 2021 · Journal of Diabetes Investigation
  7. Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
    Kyle Wolf, Jason C. Kwan, Jeremy P. Kamil · 2022 · mBio
  8. Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection
    Manpreet Singh, Obed Barrera Adame, Michael Nickas, Jeremiah Robison, Christopher Khatchadourian, Vishwanath Venketaraman · 2022 · Frontiers in Immunology
  9. SARS-CoV-2 induces Alzheimer’s disease–related amyloid-β pathology in ex vivo human retinal explants and retinal organoids
    Sean Miller, Rahul M. Dhodapkar, Hande Eda Sutova, Xue Yao, Seunghoon Lee, Robert Logan, Chongzhao Ran, Sagar Bhatta, Ashley Gomm, In Gyoung Ju et al. · 2025 · Science Advances
  10. Endolysosomes as a sorting hub for emerging viruses: Gatekeepers of cellular defense, viral fate and promising therapeutic target
    Sophie Post, Lena Rueschpler, Sebastian Schloer · 2025 · Pharmacological Research
  11. The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries
    Indriķis Krams, Priit Jõers, Severi Luoto, Giedrius Trakimas, V. Lietuvietis, Ronalds Krams, Irena Kaminska, Markus J. Rantala, Tatjana Krama · 2021 · International Journal of Environmental Research and Public Health
  12. Effects of Weight Loss on Adipose and Muscular Neuropilin 1 mRNA Expression in Obesity: Potential Implication in SARS-CoV-2 Infections?
    Dominik Soll, Finja Beer, Leonard Spranger, Linna Li, Joachim Spranger, Knut Mai · 2021 · Obesity Facts
  13. Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells
    Sokolov Av, Исакова-Сивак Ирина Николаевна, Н. А. Грудинина, Daria А. Mezhenskaya, Elena V. Litasova, Valeria A. Kostevich, Ekaterina Stepanova, Alexandra Ya. Rak, Ivan А. Sychev, Olga V. Kirik et al. · 2022 · Viruses
  14. Impact of visceral fat on the prognosis of coronavirus disease 2019: an observational cohort study
    Hiroaki Ogata, Masahiro Mori, Yujiro Jingushi, Hiroshi Matsuzaki, Katsuyuki Katahira, Akiko Ishimatsu, Aimi Enokizu‐Ogawa, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida · 2021 · BMC Infectious Diseases
  15. T Lymphocytes as Targets for SARS-CoV-2
    Е. М. Куклина · 2022 · Biochemistry (Moscow)
  16. The nervous system during COVID ‐19: Caught in the crossfire
    Nick R. Natale, John R. Lukens, William A. Petri · 2022 · Immunological Reviews
  17. The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic
    Martyna Majchrzak, Marcin Poręba · 2022 · Pharmacological Reports
  18. SARS-CoV-2 Production, Purification Methods and UV Inactivation for Proteomics and Structural Studies
    Zlatka Plavec, A. Domanska, X. Liu, P. Laine, L. Paulin, M. Varjosalo, P. Auvinen, S. Wolf, Maria Anastasina, S. Butcher · 2022 · Viruses
  19. DNA damage contributes to age‐associated differences in SARS‐CoV ‐2 infection
    Rui Jin, Chang Niu, Fengyun Wu, Sixin Zhou, Tao Han, Zhe Zhang, Entao Li, Xiaona Zhang, Shanrong Xu, Jiadong Wang et al. · 2022 · Aging Cell
  20. Incidence, risk factors and outcomes of acute kidney injury among COVID-19 patients: A systematic review of systematic reviews
    Tauqeer Hussain Mallhi, Yusra Habib Khan, Abdulaziz Ibrahim Alzarea, Faiz Ullah Khan, Nasser Hadal Alotaibi, Abdullah Salah Alanazi, Muhammad Hammad Butt, Ahmed D. Alatawi, Muhammad M. A. Salman, Sami Ibrahim Alzarea et al. · 2022 · Frontiers in Medicine
  21. The role of influenza-A virus and coronavirus viral glycoprotein cleavage in host adaptation
    Miriam Ruth Heindl, Eva Böttcher‐Friebertshäuser · 2023 · Current Opinion in Virology
  22. SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
    Shi Yu, Huina Hu, Qiangyun Ai, Rong Bai, Kaixiong Ma, Minmin Zhou, Shaobo Wang · 2023 · Viruses
  23. SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid
    A. S. Oliveira, D. Shoemark, A. Davidson, I. Berger, C. Schaffitzel, A. Mulholland · 2022 · bioRxiv
  24. Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery
    Suaidah Ramli, Yuan Seng Wu, Kalaivani Batumalaie, Rhanye Mac Guad, Ker Woon Choy, Ashok Kumar, Subash C. B. Gopinath, Md. Moklesur Rahman Sarker, Vetriselvan Subramaniyan, Mahendran Sekar et al. · 2023 · Microorganisms
  25. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo
    Nirmal Kumar, Irshad Maajid Taily, Charandeep Singh, Sahil Kumar, Raju S Rajmani, Debajyoti Chakraborty, Anshul Sharma, Priyanka Singh, Krishan Gopal Thakur, Raghavan Varadarajan et al. · 2023 · PLoS Pathogens
  26. Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
    Victória Riquena Grosche, Lucas Purificação Mendes de Souza, Giulia Magalhães Ferreira, Marco Fidel Guevara-Vega, Tamara Carvalho, Romério Rodrigues dos Santos Silva, Karla Lílian Rodrigues Batista, Rodrigo Paolo Flores Abuna, João S. Silva, Marília Freitas Calmon et al. · 2023 · Viruses
  27. NRP1 is a receptor for mammalian orthoreovirus engaged by distinct capsid subunits
    Pengcheng Shang, Rita dos Santos Natividade, G. Taylor, A. Ray, Olivia L. Welsh, K. Fiske, Danica M. Sutherland, David Alsteens, Terence S. Dermody · 2024 · Cell Host and Microbe
  28. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas)
    Silvia Preziuso · 2020 · Animals
  29. Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads
    Gaurav Joshi, Jayant Sindhu, Shikha Thakur, Abhilash Rana, Geetika Sharma, Mayank Mayank, Poduri Ramarao · 2021 · Food and Chemical Toxicology
  30. Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain
    Sultan F. Alnomasy · 2021 · Saudi Journal of Biological Sciences
  31. SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
    Filippo Scialò, Maria Vitale, Aurora Daniele, Ersilia Nigro, Fabio Perrotta, Monica Gelzo, Carlo Iadevaia, Francesco Saverio Cerqua, Adriano Costigliola, Valentino Allocca et al. · 2021 · Biomedicines
  32. Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
    Christian Zanza, Michele Fidel Tassi, Tatsiana Romenskaya, Fabio Piccolella, Ludovico Abenavoli, Francesco Franceschi, Andrea Piccioni, Veronica Ojetti, Angela Saviano, Barbara Canonico et al. · 2021 · Cells
  33. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy
    Jiang Chen, Song Li, Zhifeng Lei, Qinmin Tang, Ling Mo, Xing Zhao, Feifei Xie, Dan Zi, Jun Hao Tan · 2021 · International Journal of Biological Sciences
  34. Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis – with impact on gastrointestinal tract
    I. Berdowska, M. Matusiewicz · 2021 · World Journal of Gastroenterology
  35. SARS-CoV-2-specific neuropathology: fact or fiction?
    Anne‐Katrin Pröbstel, Lucas Schirmer · 2021 · Trends in Neurosciences
  36. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities
    Ioanna E. Galani, Evangelos Andreakos · 2021 · Seminars in Immunology
  37. In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment
    Giovanni Sartore, Davide Bassani, Eugenio Ragazzi, Pietro Traldi, Annunziata Lapolla, Stefano Moro · 2021 · Scientific Reports
  38. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
    Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding et al. · 2022 · Emerging Microbes & Infections
  39. SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
    Raluca Dumache, Alexandra Enache, Ioana Gabriela Macasoi, Cristina Adriana Dehelean, Victor Cristian Dumitrascu, Alexandra Mihailescu, Roxana Popescu, Mihaela Vlad, Cristian Sebastian Vlad, Camelia Oana Mureşan · 2022 · Pathogens
  40. The Associations between Cytokine Levels, Kidney and Heart Function Biomarkers, and Expression Levels of Angiotensin-Converting Enzyme-2 and Neuropilin-1 in COVID-19 Patients
    Rabab Hussain Sultan, Maged Abdallah, Tarek Mohamed Ali, Amr E. Ahmed, Hebatallah Hany Assal, Basem Hassan Elesawy, Osama M. Ahmed · 2022 · Vaccines
  41. SARS-CoV-2 Infection of Microglia Elicits Pro-inflammatory Activation and Apoptotic Cell Death
    Gi Uk Jeong, Jaemyun Lyu, Kyun‐Do Kim, Young Cheul Chung, Gun Young Yoon, Sumin Lee, Insu Hwang, Won-Ho Shin, Junsu Ko, June‐Yong Lee et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  42. The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome
    Jun Li, Rui Shan, H. I. Miller, Alexander V. Filatov, Maria G. Byazrova, Lu Yang, Chaohong Liu · 2025 · Cell Insight
  43. Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID: mediated by a dysfunctional immune system
    J. Massimo Nunes, Loren Kell, Anouk Slaghekke, Rob C. I. Wüst, Burtram Clinton Fielding, Douglas Bruce Kell, Etheresia Pretorius · 2026 · Cell Death and Disease
  44. Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations
    Sanmoy Pathak, Mohit Kumar Jolly, Dipankar Nandi · 2021 · Human Vaccines & Immunotherapeutics
  45. Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
    Alex van Belkum, Carina Almeida, Benjamin Bardiaux, Barrass SV, Sarah J. Butcher, Tuğçe Çaykara, Sounak Chowdhury, Rucha Datar, Ian M. Eastwood, Adrian Goldman et al. · 2021 · Diagnostics
  46. Virus structure and structure-based antivirals
    Zlatka Plavec, Ina Pöhner, Antti Poso, Sarah J. Butcher · 2021 · Current Opinion in Virology
  47. Liver, NAFLD and COVID-19
    Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti‐Weder, Louisa Licht, Reham E. Kotb, Rania Al Dweik, Michelle Cherfane, Stefan Richard Bornstein, Nikolaos Perakakis · 2022 · Hormone and Metabolic Research
  48. Chemosensory loss in COVID ‐19
    Winnie Xu, Gulshan Sunavala‐Dossabhoy, Andrew I. Spielman · 2022 · Oral Diseases
  49. SARS-COV-2/COVID-19: scenario, epidemiology, adaptive mutations, and environmental factors
    Asma Asghar, Hafiz Muhammad Imran, Naheed Bano, Sadia Maalik, Sajida Mushtaq, Asim Hussain, Sunita Varjani, Lotfi Aleya, Hafiz M.N. Iqbal, Muhammad Bilal · 2022 · Environmental Science and Pollution Research
  50. Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers
    Mehmet Arda Temena, Ahmet Acar · 2022 · Scientific Reports
  51. Localized delivery of nanomedicine and antibodies for combating COVID-19
    Bin Tu, Yanrong Gao, Xinran An, Huiyuan Wang, Yongzhuo Huang · 2022 · Acta Pharmaceutica Sinica B
  52. COVID-19 in Patients with Chronic Lung Disease
    J Calver, Laura Fabbri, James May, Gisli R. Jenkins · 2022 · Clinics in Chest Medicine
  53. High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface
    Suprama Datta, D. W. Chen, Alexander H. Tavares, Tamara Reyes Robles, Keun Ah Ryu, Nazimuddin Khan, Tyler J. Bechtel, Jayde M. Bertoch, Cory White, Daria J. Hazuda et al. · 2023 · Cell chemical biology
  54. Cryo-electron microscopy in the fight against COVID-19—mechanism of virus entry
    Satish Bodakuntla, Christopher Cyrus Kuhn, Christian Biertümpfel, Naoko Mizuno · 2023 · Frontiers in Molecular Biosciences
  55. Unique tRNA Fragment Upregulation with SARS-CoV-2 but Not with SARS-CoV Infection
    Isabella Imirowicz, Azeem Saifee, Leanne Henry, Leo Tunkle, Alexander Popescu, Philip Huang, Jibiana Jakpor, A. Barbano, Rohit Goru, Audrey L. Gunawan et al. · 2023 · International Journal of Molecular Sciences
  56. A Comprehensive Review of COVID-19-Related Olfactory Deficiency: Unraveling Associations with Neurocognitive Disorders and Magnetic Resonance Imaging Findings
    Ludovica Simonini, Francesca Frijia, Lamia Ait-Alì, Ilenia Foffa, Cecilia Vecoli, Carmelo De Gori, Sara De Cori, Monica Baroni, Giovanni Donato Aquaro, Carlo Maremmani et al. · 2024 · Diagnostics
  57. Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection
    Jessica May Vanslambrouck, Jessica Anne Neil, Rajeev Rudraraju, Sophia Mah, Ker Sin Tan, Ella Groenewegen, Thomas A. Forbes, Katerina Karavendzas, David A. Elliott, Enzo R. Porrello et al. · 2024 · Journal of Virology
  58. Novel insights into minipuberty and GnRH : Implications on neurodevelopment, cognition, and COVID ‐19 therapeutics
    Konstantina Chachlaki, Kévin Le Duc, Laurent Storme, Vincent Prévot · 2024 · Journal of Neuroendocrinology
  59. TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo
    Kexin Yan, Troy D. Dumenil, Romal Stewart, Cameron Bishop, Bing Tang, Wilson Nguyen, Andreas Suhrbier, Daniel J. Rawle · 2024 · Cell Reports
  60. Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update
    Shikha Thakur, Mayank Mayank, Bibekananda Sarkar, Arshad Jamal Ansari, Akanksha Khandelwal, Anil Arya, Poduri Ramarao, Gaurav Joshi · 2020 · Food and Chemical Toxicology
  61. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids
    Marta Trevisan, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon · 2021 · International Journal of Molecular Sciences
  62. Detection methods for SARS-CoV-2 in tissue
    Saskia Freifrau von Stillfried, Peter Boor · 2021 · Der Pathologe
  63. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes
    Edward Richardson, David García‐Bernal, Eleonora Calabretta, Rubén Jara, Marta Palomo, Rebecca Marlene Baron, Gregory Anthony Yanik, Jawed Fareed, Israël Vlodavsky, Massimo Iacobelli et al. · 2021 · Expert Opinion on Therapeutic Targets
  64. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
    Erika Cecon, Matilda Burridge, Longxing Cao, Lauren P. Carter, Rashmi Ravichandran, Julie Dam, Ralf Jockers · 2021 · Cell chemical biology
  65. The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
    Shamila D. Alipoor, Esmaeil Mortaz, Mohammad Varahram, Johan Garssen, Ian Michael Adcock · 2021 · Frontiers in Neurology
  66. Abrogation of SARS-CoV-2 interaction with host (NRP1) neuropilin-1 receptor through high-affinity marine natural compounds to curtail the infectivity: A structural-dynamics data
    Fahad Humayun, Abbas Khan, Sajjad Ahmad, Yuchen Wang, Guoshen Wei, N. Nizam‐Uddin, Zahid Hussain, Wajid Khan, Nasib Zaman, Muhammad Rizwan et al. · 2021 · Computers in Biology and Medicine
  67. Know your enemy and know yourself – the case of SARS-CoV-2 host factors
    Wai Suet Lee, Meisam Yousefi, Biaoguo Yan, Cythia Lingli Yong, Yaw Shin Ooi · 2021 · Current Opinion in Virology
  68. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells
    Jessika B. Iwanski, Sobhi G. Kazmouz, Shuaizhi Li, Ben N. Stansfield, Tori T. Salem, Samantha Perez‐Miller, Toshinobu Kazui, Lipsa Jena, Jennifer L. Uhrlaub, Scott D. Lick et al. · 2021 · Stem Cell Reports
  69. Host proviral and antiviral factors for SARS-CoV-2
    Lu Lv, Leiliang Zhang · 2021 · Virus Genes
  70. DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design
    Yang Liu, Jianhong Gan, Rongqi Wang, Xiaocong Yang, Zhi‐Xiong Jim Xiao, Yang Cao · 2022 · Molecules
  71. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques
    Chun‐Chun Gao, Man Li, Wei Deng, Chunhui Ma, Yusheng Chen, Yongqiao Sun, Tingfu Du, Qian-Lan Liu, Wenjie Li, Bing Zhang et al. · 2022 · Protein & Cell
  72. Peimine inhibits variants of SARS‐CoV ‐2 cell entry via blocking the interaction between viral spike protein and ACE2
    Wei‐Jan Wang, Yeh Chen, Wen‐Chi Su, Yen‐Yi Liu, Wan‐Jou Shen, Wei‐Chao Chang, Sheng‐Teng Huang, Cheng‐Wen Lin, Yu‐Chuan Wang, Chia‐Shin Yang et al. · 2022 · Journal of Food Biochemistry
  73. Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2
    Maarisha Upadhyay, Sanjeev Gupta · 2022 · Virus Research
  74. COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
    Jong‐Hoon Lee, Badar A. Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard Eric Kast, Chul Joong Lee, Jean Bourbeau, Eric Lewin Altschuler, Consolato Maria Sergi et al. · 2022 · International Journal of Molecular Sciences
  75. How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications
    Domenico De Berardis · 2020 · CNS Spectrums
  76. Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome
    Rebecca A. Porritt, Lisa Paschold, Magali Noval Rivas, Mary Hongying Cheng, Lael M. Yonker, Harsha K. Chandnani, Merrick Lopez, Donjetë Simnica, Christoph Schultheiß, Chintda Santiskulvong et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  77. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
    Josephine Lampe, Jan Wenzel, Helge Müller‐Fielitz, Kristin Müller, Raphael Schuster, Linlin Zhang, Marietta Zille, Markus Krohn, Ümit Özorhan, Yun Jiang et al. · 2020
  78. Quo vadis? Central Rules of Pathogen and Disease Tropism
    Laura‐Isobel McCall · 2021 · Frontiers in Cellular and Infection Microbiology
  79. Nanoparticles and essential oils with antiviral activity on packaging and surfaces: An overview of their selection and application
    Ronald Márquez, Jacob D. Zwilling, Franklin Zambrano, Laura I. Tolosa, Maria E. Marquez, Richard A. Venditti, Hasan Jameel, Ronalds González · 2022 · Journal of Surfactants and Detergents
  80. In Silico and In Vitro Studies of Alchemilla viridiflora Rothm—Polyphenols’ Potential for Inhibition of SARS-CoV-2 Internalization
    Relja V. Suručić, Jelena Radović, Tatjana Kundaković, Biljana Lazović, Maja Travar, Ljiljana T. Suručić, Ranko Škrbić · 2022 · Molecules
  81. Druggable targets and therapeutic development for COVID-19
    Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen · 2022 · Frontiers in Chemistry
  82. The Role of Host Cell Glycans on Virus Infectivity: The SARS‐CoV‐2 Case
    Silvia Acosta‐Gutiérrez, Joseph Buckley, Giuseppe Battaglia · 2022 · Advanced Science
  83. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches
    Shahrzad Ahmadi, Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh · 2022 · Molecular Immunology
  84. Role and clinical implication of autophagy in COVID-19
    Tianlong Shan, Lanya Li, Jinming Yang, Yan Cheng · 2023 · Virology Journal
  85. The immune mechanism of the nasal epithelium in COVID-19–related olfactory dysfunction
    Shunmei Chen, Shufen Wang · 2023 · Frontiers in Immunology
  86. Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
    Sheetal Uppal, Olga A. Postnikova, Rafael Villasmil, Igor B. Rogozin, Alexander V. Bocharov, Thomas L. Eggerman, Eugenia Poliakov, T. Michael Redmond · 2023 · International Journal of Molecular Sciences
  87. Immune landscape and redox imbalance during neurological disorders in COVID-19
    Abhimanyu Thakur, Vartika Sharma, Sera Averbek, Lifan Liang, Nirali Pandya, Gaurav Kumar, Alma Cili, Kui Zhang · 2023 · Cell Death and Disease
  88. COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage
    Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf · 2024 · Molecular Biology Reports
  89. Structures and functions of the normal and injured human olfactory epithelium
    Shu Kikuta, Shin Nagayama, Sanae Hasegawa‐Ishii · 2024 · Frontiers in Neural Circuits
  90. SARS-CoV-2 Rapidly Infects Peripheral Sensory and Autonomic Neurons, Contributing to Central Nervous System Neuroinvasion before Viremia
    Jonathan D. Joyce, Greyson A. Moore, Poorna Goswami, Telvin L. Harrell, Tina M. Taylor, Seth A. Hawks, Jillian C. Green, Mo Jia, Matthew D. Irwin, Emma H. Leslie et al. · 2024 · International Journal of Molecular Sciences
  91. Rectifying COVID-19 disparities with treatment and vaccination
    John M. Carethers · 2021 · JCI Insight
  92. Comparative Sequence Analysis of SARS-CoV-2 Suggests Its High Transmissibility and Pathogenicity
    Kartika Padhan, Mohammad Khalid Parvez, Mohammed Salem Al-Dosari · 2021 · Future Virology
  93. Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
    Georgina I. López-Cortés, Miryam Palacios-Pérez, Gabriel S. Zamudio, Hannya F. Veledíaz, Enrique Ortega, Marco V. José · 2021 · Scientific Reports
  94. Human models for COVID‐19 research
    Maximillian N. J. Woodall, Tereza Masonou, Katie‐Marie Case, Claire Mary Smith · 2021 · The Journal of Physiology
  95. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development
    Niel Alexander Karrow, Umesh Kumar Shandilya, Steven Pelech, Lauraine Wagter-Lesperance, Deanna McLeod, Byram W. Bridle, Bonnie A. Mallard · 2021 · Vaccines
  96. The Unfavorable Clinical Outcome of COVID-19 in Smokers is Mediated by H3K4me3, H3K9me3 and H3K27me3 Histone Marks
    Milad Shirvaliloo · 2022 · Epigenomics
  97. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
    Yadira Palacios, Leslie Chávez‐Galán · 2022 · Pharmaceuticals
  98. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2
    Zsolt Fazekas, Dóra K. Menyhárd, András Perczel · 2022 · Journal of Chemical Information and Modeling
  99. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
    Saeid Najafi Fard, Linda Petrone, Elisa Petruccioli, Tonino Alonzi, Giulia Matusali, Francesca Colavita, Concetta Castilletti, Maria Rosaria Capobianchi, Delia Goletti · 2021 · BioMed Research International
  100. Myeloid dysregulation and therapeutic intervention in COVID-19
    Runxia Gu, Tianyang Mao, Lu Qiao, Tina Tianjiao Su, Jun Wang · 2021 · Seminars in Immunology